Sars-Cov-2 Mrna-1273 (6Y-11Y) Vaccine Dosage

Usual Pediatric Dose for COVID-19

For investigational use only

6 through 11 years:

• Primary series: 0.5 mL IM for 2 doses, administered 1 month apart

Comments:

• The US FDA issued an Emergency Use Authorization (EUA) to allow the emergency use of this unapproved product for active immunization to prevent coronavirus disease 2019 (COVID-19). This product is not approved by the US FDA for this use.
• There are no data available regarding interchangeability of COVID-19 vaccine products; the same vaccine product should be used for both doses.
• For additional information: https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization

Use: Active immunization against COVID-19 due to SARS-CoV-2 (SARS-CoV-2)

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

CONTRAINDICATIONS: None

Safety and efficacy have not been established in patients younger than 6 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

• Administer IM.
• Gently swirl the vial between doses; do not shake.

Storage requirements:

• Store frozen between -50C to -15C (-58F to 5F); store in original package to protect from light.

• Thaw each vial before use; once thawed, do not return vial to freezer.
• Thawed vials may be handled in room light conditions.
• Vials may be stored between 8C and 25C (46F to 77F) for a total of 24 hours.
• Thawing vials: Consult the Fact Sheet for Health Care Providers.
• May store vials in refrigerator between 2C to 8C (36F to 46F) for up to 30 days prior to first use.
• In use vial (needle-punctured): Store between 2C to 25C (36F to 77F); discard vial 12 hours after first puncture.
• Do not refreeze.

Reconstitution/preparation techniques:

• Do not dilute.
• Consult the Fact Sheet for Health Care Providers.

General:

• Each 0.5 mL dose contains 50 mcg of a nucleoside-modified messenger RNA encoding the viral spike (S) glycoprotein of SARS-CoV-2.

Patient advice:

• Read the Fact Sheet for Recipients and Caregivers.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer